<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Arch Immunol Ther Exp (Warsz)</journal-id>
<journal-id journal-id-type="iso-abbrev">Arch. Immunol. Ther. Exp. (Warsz.)</journal-id>
<journal-title-group>
<journal-title>Archivum Immunologiae et Therapiae Experimentalis</journal-title>
</journal-title-group>
<issn pub-type="ppub">0004-069X</issn>
<issn pub-type="epub">1661-4917</issn>
<publisher>
<publisher-name>Springer International Publishing</publisher-name>
<publisher-loc>Cham</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27178663</article-id>
<article-id pub-id-type="pmc">5085986</article-id>
<article-id pub-id-type="publisher-id">394</article-id>
<article-id pub-id-type="doi">10.1007/s00005-016-0394-x</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Adipose-Derived Stem Cells as a Tool in Cell-Based Therapies</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes">
<name>
<surname>Bajek</surname>
<given-names>Anna</given-names>
</name>
<address>
<email>a_bajek@wp.pl</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Gurtowska</surname>
<given-names>Natalia</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Olkowska</surname>
<given-names>Joanna</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kazmierski</surname>
<given-names>Lukasz</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maj</surname>
<given-names>Malgorzata</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Drewa</surname>
<given-names>Tomasz</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<aff id="Aff1"><label>1</label>Department of Tissue Engineering, Nicolaus Copernicus University, Karłowicza 24, 85-092 Bydgoszcz, Poland </aff>
<aff id="Aff2"><label>2</label>Department of Urology, Nicolaus Copernicus Hospital, Torun, Poland </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>13</day>
<month>5</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>13</day>
<month>5</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2016</year>
</pub-date>
<volume>64</volume>
<issue>6</issue>
<fpage>443</fpage>
<lpage>454</lpage>
<history>
<date date-type="received">
<day>30</day>
<month>9</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>1</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2016</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p>Recent development in stem cell isolation methods and expansion under laboratory conditions create an opportunity to use those aforementioned cells in tissue engineering and regenerative medicine. Particular attention is drawn towards mesenchymal stem cells (MSCs) being multipotent progenitors exhibiting several unique characteristics, including high proliferation potential, self-renewal abilities and multilineage differentiation into cells of mesodermal and non-mesodermal origin. High abundance of MSCs found in adipose tissue makes it a very attractive source of adult stem cells for further use in regenerative medicine applications. Despite immunomodulating properties of adipose-derived stem cells (ASCs) and a secretion of a wide variety of paracrine factors that facilitate tissue regeneration, effectiveness of stem cell therapy was not supported by the results of clinical trials. Lack of a single, universal stem cell marker, patient-to-patient variability, heterogeneity of ASC population combined with multiple widely different protocols of cell isolation and expansion hinder the ability to precisely identify and analyze biological properties of stem cells. The above issues contribute to conflicting data reported in literature. We will review the comprehensive information concerning characteristic features of ASCs. We will also review the regenerative potential and clinical application based on various clinical trials.</p>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Adipose-derived stem cells</kwd>
<kwd>Adipose tissue</kwd>
<kwd>Clinical trials</kwd>
<kwd>Regenerative medicine</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© L. Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland 2016</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Introduction</title>
<p>In the past, adipose tissue was considered only a passive energy storage. Since the mid-80’s of the last century, when its participation in the metabolism of sex hormones was confirmed, adipose tissue has become an important endocrine organ that controls metabolism, immunity and satiety (Seo et al. <xref ref-type="bibr" rid="CR78">2004</xref>). The real breakthrough was made in 2001 when a new source of adult stem cells, called adipose-derived stem cells (ASCs), isolated from adipose tissue, was described for the first time (Zuk et al. <xref ref-type="bibr" rid="CR101">2001</xref>).</p>
<p>Adipose tissue is considered a type of connective tissue exhibiting morphological, functional and regulatory heterogeneity (Furstenberg et al. <xref ref-type="bibr" rid="CR28">2010</xref>). The interaction between adipose tissue and other tissues or organs is certainly bidirectional (Skowrońska et al. <xref ref-type="bibr" rid="CR80">2005</xref>). It affects the functioning of most physiological systems, including the immune, reproductive, and hematopoietic system (Baptista et al. <xref ref-type="bibr" rid="CR7">2015</xref>). Development, amount and distribution of adipose tissue in the body is a result of the nervous system, hormones and transcription factors effects (Baptista et al. <xref ref-type="bibr" rid="CR7">2015</xref>; Furstenberg et al. <xref ref-type="bibr" rid="CR28">2010</xref>). In terms of macroscopic features five types of adipose tissue [bone marrow (BM), brown and white mammary glands and mechanical adipose tissue] can be distinguished, each of them with a different, distinct biological function (Gimble et al. <xref ref-type="bibr" rid="CR29">2007</xref>).</p>
<p>Since the identification of stem cells in the BM over 40 years ago, they have become a standard in the field of tissue engineering and regenerative medicine (Friedenstein et al. <xref ref-type="bibr" rid="CR26">1968</xref>; Lindroos et al. <xref ref-type="bibr" rid="CR54">2011</xref>). Bone marrow aspiration, however, is a painful and expensive procedure that requires general anesthesia. Moreover, the yield of isolated cells is usually low (Lindroos et al. <xref ref-type="bibr" rid="CR54">2011</xref>). Multipotent mesenchymal stem cells (MSCs) are present in a number of postnatal organs and connective tissues. MSCs, with similar characteristics to BM-derived MSCs, have been successfully isolated from different tissue sources including periosteum, synovium, skeletal muscle, skin, peripheral blood and umbilical cord (Kuroda et al. <xref ref-type="bibr" rid="CR47">2011</xref>). Although the stem cell populations derived from these sources are valuable, common problems include low harvested cells yield and limited amount of harvested tissues. Adipose tissue seems to be a great alternative source of acquiring stem cells, especially with the increased incidence of obesity which makes the tissue abundant and readily accessible. It can be collected in large quantities with low possibility of donor site morbidity, during a much safer and less time consuming liposuction procedure (Uzbas et al. <xref ref-type="bibr" rid="CR87">2015</xref>). Approximately 400,000 liposuction surgeries are performed in the US each year and these procedures yield from 100 ml to &gt;3 l of lipoaspirate tissue, which is routinely discarded (Bunnell et al. <xref ref-type="bibr" rid="CR10">2008</xref>). Furthermore, the high content of ASCs in adipose tissue, excludes the need of long-term in vitro culture, what reduces the risk of chromosomal abnormalities. Such properties make the ASCs an attractive tool in clinical application for therapeutic purposes (Baptista et al. <xref ref-type="bibr" rid="CR7">2015</xref>; Nakagami et al. <xref ref-type="bibr" rid="CR60">2006</xref>; Uzbas et al. <xref ref-type="bibr" rid="CR87">2015</xref>).</p>
</sec>
<sec id="Sec2">
<title>Collection of Adipose Tissue: Liposuction</title>
<p>The method of adipose tissue collection, for the purpose of stem cell isolation, raises a number of controversies. Researchers are eager to use adipose tissue, which is considered a waste product of abdominoplasty, cosmetic surgery or liposuction (Gimble et al. <xref ref-type="bibr" rid="CR30">2010</xref>). Liposuction is currently the most common aesthetic surgery widely used around the world. The first step is the infiltration of the fat (of the area to be aspirated) using a large amount of the lidocaine, epinephrine, sodium bicarbonate, and saline composition (to reduce the risk of blood loss). Infiltration methods include the super-wet technique (1 ml infiltration per 1 ml aspiration) and the tumescent technique (2–3 infiltration cm<sup>3</sup> per 1 cm<sup>3</sup> aspiration) (Heymans et al. <xref ref-type="bibr" rid="CR36">2006</xref>). Subsequently the separated fat tissue with the injected solution is aspirated via a cannula of different diameter (Sood et al. <xref ref-type="bibr" rid="CR81">2011</xref>; Vivek et al. <xref ref-type="bibr" rid="CR89">2014</xref>).</p>
<p>Several liposuction techniques such as standard liposuction, suction assisted liposuction, internal ultrasound assisted liposuction, external ultrasound assisted liposuction, laser assisted liposuction, power-assisted liposuction, and vibroliposuction are currently in clinical use (Heymans et al. <xref ref-type="bibr" rid="CR36">2006</xref>). A brief description of selected methods is shown in Table <xref ref-type="table" rid="Tab1">1</xref>.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Characteristic of selected liposuction methods</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Technique</th><th align="left">Characteristic</th></tr></thead><tbody><tr><td align="left">Standard and suction assisted liposuction</td><td align="left">Aspirating the tissue at high pressure with a large diameter cannula without prior infiltration (dry technique, now rarely used)</td></tr><tr><td align="left" colspan="2">Tumescent techniques</td></tr><tr><td align="left"> Ultrasound-assisted liposuction</td><td align="left">Emulsifying the fat tissue with a vibrating at high ultrasound probe, emulsion removal by the small diameter cannula</td></tr><tr><td align="left"> Power-assisted liposuction</td><td align="left">The separation of adipose tissue by the set forward and backward motion cannula, divided fat tissue is sucked into the cannula, considered as the safest and most effective method</td></tr><tr><td align="left"> Laser-assisted liposuction</td><td align="left">Adipocytes separation and liquidation of tissue via a cannula emitting the laser ray, gentle aspiration of the liquid fat tissue through the cannula</td></tr></tbody></table><table-wrap-foot><p>Modified according to Heymans et al. (<xref ref-type="bibr" rid="CR36">2006</xref>)</p><p>There are several liposuction techniques currently available to remove fatty tissue from different sites on the human body. In the tumescent techniques, that reduce post operative bruising, swelling and pain in comparison to older more traditional methods, subcutaneous fat is injected with a large volume of diluted anesthetic and capillary constrictor before liposuction is performed</p></table-wrap-foot></table-wrap>
</p>
<p>Depending on the technique and location, the liposuction procedures are performed under local, peripheral or general anesthesia (Sood et al. <xref ref-type="bibr" rid="CR81">2011</xref>). Liposuction is regarded as a generally safe and well-tolerated procedure with minimal post-operative discomfort. The study performed by the American Society for Dermatologic showed no recorded deaths at nearly 70,000 liposuction procedures carried out between 1994 and 2000, and serious adverse events were very rare at the rate of 0.68 per 1000 cases (Fraser et al. <xref ref-type="bibr" rid="CR24">2006</xref>). Compared to the BM aspiration, liposuction procedures are much less invasive, cheaper, and even a small amount of adipose tissue (100–200 ml) is enough to isolate a suitable number of stem cells under local anesthesia (Orbay et al. <xref ref-type="bibr" rid="CR63">2012</xref>). Other methods such as syringe-based harvest may give higher yields of adipocytes but are not as widely used as vacuum liposuction (Eto et al. <xref ref-type="bibr" rid="CR22">2009</xref>). Surgical fat excision being more invasive may be used less often but the ASC’s yield is over 50 % higher compared to liposuction (Fraster et al. <xref ref-type="bibr" rid="CR25">2007</xref>).</p>
</sec>
<sec id="Sec3">
<title>The Stromal Vascular Fraction</title>
<p>Isolation procedures of fat tissue components are convergent in the standard methods, based on enzymatic digestion. Those methods are designed to separate the two easily recognizable fractions, mature adipocytes and the stromal vascular fraction (SVF). After collagenase digestion, mature adipocytes with a high fat content are separated as a floating layer. All cells, which remain after the removal of mature adipocytes constitute the SVF (Peinado et al. <xref ref-type="bibr" rid="CR65">2012</xref>). The composition of the SVF varies among individual research groups. It is commonly known, however, that it includes preadipocytes, endothelial cells, pericytes, fibroblasts, ASCs and hematopoietic stem cells (Peinado et al. <xref ref-type="bibr" rid="CR65">2012</xref>; Zuk et al. <xref ref-type="bibr" rid="CR101">2001</xref>). The SVF also contains erythrocytes, lymphocytes T, B cells, macrophages, and mast cells (Peinado et al. <xref ref-type="bibr" rid="CR65">2012</xref>). Stem cells and progenitor cells determine about 3 % of all cell populations (Tsuji et al. <xref ref-type="bibr" rid="CR85">2014</xref>).</p>
<p>Cytometric analysis performed by Yoshimura et al. (<xref ref-type="bibr" rid="CR93">2006</xref>) identified the following cell populations in SVF: ASCs (CD31<sup>−</sup>/CD34<sup>+</sup>/CD45<sup>−</sup>/CD90<sup>+</sup>/CD105<sup>−</sup>/CD146<sup>−</sup>), endothelial progenitor cells (CD31<sup>+</sup>/CD34<sup>+</sup>/CD45<sup>−</sup>/CD90<sup>+</sup>/CD105<sup>low</sup>/CD146<sup>++</sup>), pericytes (CD31<sup>−</sup>/CD34<sup>−</sup>/CD45<sup>−</sup>/CD90<sup>+</sup>/CD105<sup>−</sup>/CD146<sup>+</sup>) and blood cells (CD45<sup>+</sup>), suggesting also the presence of fibroblasts, vascular smooth muscle cells and preadipocytes. Taking into account the surface markers expression, the heterogeneous isolates of SVF can be represented as follows: 11 % CD2<sup>+</sup> cells, 18 % CD11a<sup>+</sup> cells, 29 % CD14<sup>+</sup> cells, 49 % CD31<sup>+</sup> cells, 57 % CD45<sup>+</sup> cells and 60 % CD90<sup>+</sup> cells (Brzoska et al. <xref ref-type="bibr" rid="CR9">2005</xref>). Another research group presented composition of SVF slightly different: 11 % CD14<sup>+</sup> cells, ~2 % CD31<sup>+</sup> cells, ~7 % CD34<sup>+</sup> cells, ~9 % CD45<sup>+</sup> cells, ~29 % CD90<sup>+</sup> cells and ~47 % CD146<sup>+</sup> cells (Astori et al. <xref ref-type="bibr" rid="CR1">2007</xref>). It was also observed that 85 % SVF cells, which underwent adhesion, exhibit the CD31<sup>−</sup>/CD34<sup>+</sup>/CD45<sup>−</sup>/CD105<sup>+</sup> phenotype (Varma et al. <xref ref-type="bibr" rid="CR88">2007</xref>). The expression of hematopoietic markers such as CD11, CD14, CD34, and CD45 dissipate is lost during the SVF in vitro passaging. On the other hand, the expression level of some markers, e.g. CD29, CD73, CD90, and CD166 increases in higher passages (Tsuji et al. <xref ref-type="bibr" rid="CR85">2014</xref>). That is why passaging is considered a selecting factor when it comes to cell populations with more homogenous cell surface markers compared to SVF.</p>
</sec>
<sec id="Sec4">
<title>Isolation of ASCs from Adipose Tissue</title>
<p>For the first time the isolation of rat mature adipocytes and adipose tissue progenitor cells was described by Rodbell (<xref ref-type="bibr" rid="CR70">1964</xref>). The protocol was based on the disintegration of adipose tissue into small fragments followed by enzymatic digestion with collagenase type I in 37 °C and the following centrifugation to separate distinct cell fractions. The obtained supernatant was composed of mature adipocytes and the pellet fraction consisted of the SVF components, in which the progenitor cells of adipocytes were presumably present. This procedure was effectively modified and used with small volumes of fat tissue by many research groups like (Cawthorn et al. <xref ref-type="bibr" rid="CR13">2012</xref>; Tsuji et al. <xref ref-type="bibr" rid="CR85">2014</xref>).</p>
<p>Katz et al. (<xref ref-type="bibr" rid="CR42">1999</xref>), Zuk et al. (<xref ref-type="bibr" rid="CR101">2001</xref>) and Uzbas et al. (<xref ref-type="bibr" rid="CR87">2015</xref>) demonstrated that SVF isolated from human lipoaspirates contains multipotent cells. To isolate these cells enzymatic digestion was used followed by their adhesion to the bottom of culture flasks. Enzymatic digestion and adhesion properties of ASCs still comprise the basis of their isolation (Lindroos et al. <xref ref-type="bibr" rid="CR54">2011</xref>). One of the novel methods of ASCs isolation is the use of antibody-coated immunomagnetic beads, which are able not only to “catch” ASCs cells, but also other subpopulations of stem cells found in adipose tissue (Rada et al. <xref ref-type="bibr" rid="CR68">2009</xref>).</p>
<p>Katz et al. (<xref ref-type="bibr" rid="CR43">2001</xref>) developed a device known as the “bag within a bag”, which enables the aspiration of pre-injected saline and tissue to the inner bag. This system is extremely useful for contamination removal and helps to automate the isolation protocol to some degree (Katz et al. <xref ref-type="bibr" rid="CR43">2001</xref>). The same group developed a rotary, temperature control device to digest even 1 l of tissue at a time (Katz et al. <xref ref-type="bibr" rid="CR42">1999</xref>). In addition to the cell isolation it also separates the extracellular matrix of adipose tissue, which may be used as a potent biomaterial.</p>
<p>Isolation of ASCs on a large scale is possible with the use of commercially available systems, such as CelutionTM (Cytori Therapeutics, San Diego, USA) (Lin et al. <xref ref-type="bibr" rid="CR53">2008b</xref>; Tissue Genesis Incorporated <xref ref-type="bibr" rid="CR84">2009</xref>). These systems allow for fast and safe isolation of large numbers of autologous stem cells, ready for immediate application. CelutionTM Cytori system was used in a clinical trial of stress urinary incontinence treatment, which showed promising results (Yamamoto et al. <xref ref-type="bibr" rid="CR90">2010</xref>).</p>
<p>The most important advantage of ASCs is their abundance. From 1 g of adipose tissue an average of 0.5–2.0 × 10<sup>6</sup> SVF cells can be isolated, which gives 1–10 % of stem cells yield (Bear et al. <xref ref-type="bibr" rid="CR8">2013</xref>) for comparison MSCs constitute 0.001–0.01 % of BM (Pittenger et al. <xref ref-type="bibr" rid="CR66">1999</xref>). Some sources claim that the number of isolated cells can be even greater, and amount to about 2–6 × 10<sup>6</sup> cells from 1 ml of tissue (Kim and Jeong <xref ref-type="bibr" rid="CR46">2014</xref>). The number of ASCs isolated from 1 g of fat tissue ranges between 0.5 × 10<sup>4</sup> and 2 × 10<sup>5</sup> (Baer and Geiger <xref ref-type="bibr" rid="CR5">2012</xref>). These differences are caused by donor characteristics, such as gender, age, ethnicity, BMI, disease history and also the type of fat tissue (yellow/brown), location (subcutaneous/visceral fat) and the tissue collection method or culture conditions (Baer and Geiger <xref ref-type="bibr" rid="CR5">2012</xref>; Olkowska-Truchanowicz <xref ref-type="bibr" rid="CR62">2008</xref>).</p>
</sec>
<sec id="Sec5">
<title>Impact of Culture on Senescence and Genetic Stability of ASCs</title>
<p>The protocol of ASCs culture varies between laboratories and currently there is not a single, unified method available. Most commonly it is a monolayer culture in standard medium supplemented with 10 % fetal bovine serum (Mizuno et al. <xref ref-type="bibr" rid="CR58">2012</xref>). The growth factors can affect the undifferentiated state of ASCs. Under in vitro conditions stem cells phenotype may be affected by growth medium used for ASC culture, specific supplements added to basic growth medium and environment conditions at which cells are grown. Even the use of serum-containing standard medium may induce their differentiation. Under in vitro conditions ASC’s phenotype may be affected by a wide variety of factors, ranging from growth medium choice and the type of supplementation used (serum, platelet lysate, growth factors, corticoids, antioxidants) to environment and culture conditions such as culture perfusion, mechanical load, confluence level or substance stiffness. ASC’s are also especially sensitive to oxygen levels, if possible complete hypoxia condition would be best for their culturing (Baer and Geiger <xref ref-type="bibr" rid="CR5">2012</xref>).</p>
<p>In comparison to BM-MSCs, ASCs have a higher proliferative capability. The population doubling time, in the logarithmic growth phase, ranges 40–120 h and depends on age of the donor, type and location of the adipose tissue, method of collection, culture conditions, cells density and medium composition used by teams of De Ugarte et al. (<xref ref-type="bibr" rid="CR19">2003</xref>), Izadpanah et al. (<xref ref-type="bibr" rid="CR39">2006</xref>), Mitchell et al. (<xref ref-type="bibr" rid="CR56">2006</xref>) and Zuk et al. (<xref ref-type="bibr" rid="CR101">2001</xref>). ASCs show telomerase activity, and although it is lower than in the tumor cell lines, it testifies the ability of ASCs for self-renewal and proliferation (Jeon et al. <xref ref-type="bibr" rid="CR40">2011</xref>). These cells maintain telomere length during long-term culture, but whether telomerase activity is sustained at a constant level or decreases with successive passages is still open to debate (Izadpanah et al. <xref ref-type="bibr" rid="CR39">2006</xref>; Jeon et al. <xref ref-type="bibr" rid="CR40">2011</xref>). Sachs et al. (<xref ref-type="bibr" rid="CR74">2012</xref>) documented the lack of telomerase expression in ASCs. Moreover, telomeres were gradually shortening with age, indicating a telomere-based senescence mechanism (Sachs et al. <xref ref-type="bibr" rid="CR74">2012</xref>).</p>
<p>Taking into account that stem cells previously cultured in vitro can be safely transplanted, there is a great need to further investigate their abilities to maintain chromosome stability in non-physiological conditions. ASCs exhibit higher genetic stability in long-term culture compared to BM-MSCs (Dahl et al. <xref ref-type="bibr" rid="CR18">2008</xref>; Neri et al. <xref ref-type="bibr" rid="CR61">2013</xref>). However, research carried out by at least one research group has shown that karyotype irregularities occur with a frequency of &gt;30 %. The occurrence of neoplastic transformation of ASCs maintained in culture for more than four months was also observed (Rubio et al. <xref ref-type="bibr" rid="CR73">2005</xref>). The relevance of a clear tendency towards increased aneuploidy with in vitro culture is still being debated (Sensebe et al. <xref ref-type="bibr" rid="CR77">2012</xref>). It appears crucial to perform a detailed analysis of the genome prior to any cell-based treatment. Special caution in conducting and selecting the ASCs culture is needed, as it can be crucial for maintaining their diplioidal karyotype.</p>
</sec>
<sec id="Sec6">
<title>Phenotype and Niche of ASCs</title>
<p>All previous attempts to determine the phenotype of ASCs and identification of one unique marker for these cells were unsuccessful. It is assumed that these cells express following markers: CD13, CD29, CD44, CD49b, CD90, CD105 and do not express the hematopoietic markers, such as CD14, CD31, CD45 and CD144 as described by Zuk (<xref ref-type="bibr" rid="CR100">2013</xref>). Additional studies, evaluating the ASCs differentiation, suggested that these cells have a specific expression of CD34 marker and the absence of CD31/CD45 (Varma et al. <xref ref-type="bibr" rid="CR88">2007</xref>; Yoshimura et al. <xref ref-type="bibr" rid="CR93">2006</xref>). The expression profile of cell surface markers of human ASCs is presented in Table <xref ref-type="table" rid="Tab2">2</xref>.<table-wrap id="Tab2"><label>Table 2</label><caption><p>The expression profile of ASCs surface markers</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Protein</th><th align="left">Name</th><th align="left">CD</th></tr></thead><tbody><tr><td align="left" colspan="3">Positive expression</td></tr><tr><td align="left" rowspan="5"> Adhesion molecules</td><td align="left">Tetraspan protein</td><td align="left">CD9</td></tr><tr><td align="left">β-1 integrin</td><td align="left">CD29</td></tr><tr><td align="left">Sialomucin</td><td align="left">CD34</td></tr><tr><td align="left">α-4 integrin</td><td align="left">CD49d</td></tr><tr><td align="left">Intercellular adhesion molecule-1</td><td align="left">CD54 (ICAM-1)</td></tr><tr><td align="left" rowspan="3"> Receptor molecules</td><td align="left">Hyaluronan receptor</td><td align="left">CD44</td></tr><tr><td align="left">Transferrin receptor</td><td align="left">CD71</td></tr><tr><td align="left">α-Platelet-derived growth factor</td><td align="left">CD140a</td></tr><tr><td align="left" rowspan="3"> Enzymes</td><td align="left">Neutral endopeptidase</td><td align="left">CD10 (CALLA)</td></tr><tr><td align="left">Aminopeptidase</td><td align="left">CD13</td></tr><tr><td align="left">Ecto-5′-nucleotidase</td><td align="left">CD73</td></tr><tr><td align="left" rowspan="5"> Extracellular matrix proteins and glycoproteins</td><td align="left">Collagen I</td><td align="left">–</td></tr><tr><td align="left">Collagen III</td><td align="left">–</td></tr><tr><td align="left">Osteopontin</td><td align="left">–</td></tr><tr><td align="left">Osteonectin</td><td align="left">CD90</td></tr><tr><td align="left">Thy-1</td><td align="left"></td></tr><tr><td align="left"> Cytoskeletal proteins</td><td align="left">Vimentin</td><td align="left">–</td></tr><tr><td align="left" rowspan="2"> Regulatory proteins of the complement system</td><td align="left">Complement decay-accelerating factor</td><td align="left">CD55</td></tr><tr><td align="left">MAC-inhibitory protein</td><td align="left">CD59</td></tr><tr><td align="left"> Histocompatibility proteins</td><td align="left">HLA-A, -B, -C (class I)</td><td align="left">–</td></tr><tr><td align="left" colspan="3">Negative expression</td></tr><tr><td align="left" rowspan="6"> Adhesion molecules</td><td align="left">Vascular cell adhesion protein 1</td><td align="left">CD106 (VCAM)</td></tr><tr><td align="left">Lymphocyte function-associated antigen 1</td><td align="left">CD11a</td></tr><tr><td align="left">Mac-1a</td><td align="left">CD11b</td></tr><tr><td align="left">Integrin α-X</td><td align="left">CD11c</td></tr><tr><td align="left">Platelet endothelial cell adhesion molecule</td><td align="left">CD31</td></tr><tr><td align="left">VE-cadherin</td><td align="left">CD144</td></tr><tr><td align="left"> Receptor molecules</td><td align="left">LPS receptor</td><td align="left">CD14</td></tr><tr><td align="left"> Enzymes</td><td align="left">Tyrosine phosphatase</td><td align="left">CD45</td></tr><tr><td align="left" colspan="3">Controversy expression</td></tr><tr><td align="left" rowspan="3"> Adhesion molecules</td><td align="left">Endoglin</td><td align="left">CD105</td></tr><tr><td align="left">MUC-18</td><td align="left">CD146</td></tr><tr><td align="left">Activated leukocyte cell adhesion molecule</td><td align="left">CD166 (ALCAM)</td></tr><tr><td align="left"> Receptor molecules</td><td align="left">Platelet derived growth factor receptor</td><td align="left">CD140b</td></tr><tr><td align="left"> Muscle proteins</td><td align="left">Smooth muscle actin</td><td align="left">–</td></tr><tr><td align="left"> Histocompatibility proteins</td><td align="left">HLA-DR</td><td align="left">–</td></tr></tbody></table><table-wrap-foot><p>Modified according to Zuk (<xref ref-type="bibr" rid="CR100">2013</xref>)</p><p>Adipose-derives stem cells exhibit specific cell surface expression pattern. Despite intensive search single unique marker have not been identified. ASCs are mainly identified on the basis of their high expression of CD105, CD90, CD44, CD73 in the absence of CD34, CD14 and CD45</p></table-wrap-foot></table-wrap>
</p>
<p>Stem cell niche is a microenvironment, which controls the properties of stem cells and gene expression. It consists of signaling molecules, interactions between cells themselves, stem cells and the extracellular matrix (Fuchs et al. <xref ref-type="bibr" rid="CR27">2004</xref>). The niche of ASCs in adipose tissue has not been clarified. However, a number of recent studies indicate that it can be identified in adipose tissue vascularization process like shown by (Leto Barone et al. <xref ref-type="bibr" rid="CR50">2013</xref>; Lin et al. <xref ref-type="bibr" rid="CR52">2008a</xref>; Zimmerlin et al. <xref ref-type="bibr" rid="CR98">2010</xref>). Zimmerlin et al. (<xref ref-type="bibr" rid="CR98">2010</xref>) identified the ASCs on outer adventitia of blood vessels. Expression of CD146 and 3G5 and the pericytes markers suggests that these cells can be identified as pericytes located in the vasculature of adipose tissue (Crisan et al. <xref ref-type="bibr" rid="CR17">2008</xref>; Zannettino et al. <xref ref-type="bibr" rid="CR96">2008</xref>). This hypothesis may enhance the fact that processes like adipogenesis and angiogenesis are closely related, adipose tissue is a highly vascularized tissue, and pericytes exhibit similar multipotency as stem cells (Crandall et al. <xref ref-type="bibr" rid="CR16">1997</xref>; Feng et al. <xref ref-type="bibr" rid="CR23">2010</xref>; Zannettino et al. <xref ref-type="bibr" rid="CR96">2008</xref>).</p>
<p>Expression of CD146 by ASCs, however, raises a lot of doubt. It also impedes the possibility of confirmation that pericytes and ASCs are the same cells (Sensebe et al. <xref ref-type="bibr" rid="CR77">2012</xref>). Moreover, Maumus et al. (<xref ref-type="bibr" rid="CR55">2011</xref>) in immunohistological analysis presented that native ASCs exhibit specific morphological characteristics. In addition, native ASCs can be found in the adipose tissue matrix. An argument against the classification of ASCs as pericytes militates is the fact that they do not express markers characteristic to pericytes in vivo, such as NG2, CD140b or alpha smooth muscle actin (expression occurs during in vitro culture) (Casteilla et al. <xref ref-type="bibr" rid="CR12">2011</xref>). Rodeheffer et al. (<xref ref-type="bibr" rid="CR71">2008</xref>) identified another subpopulation of early adipocyte progenitor cells in a mice model (Lin<sup>−</sup>, CD29<sup>+</sup>, CD34<sup>+</sup>, Sca-1<sup>+</sup>, CD24<sup>+</sup>), which is located in white adipose tissue.</p>
<p>The cause of contradictions concerning the profile of ASCs is not known. It may have emerged as a result of various isolation and cultivation methods used or various location-dependent origins of ASCs (Casteilla et al. <xref ref-type="bibr" rid="CR12">2011</xref>). The presence of several stem cell populations within SVF of adipose tissue, such as endothelial precursor cell population, population of perivascular ASCs or pericytes population can also be the reason of that problem (Tsuji et al. <xref ref-type="bibr" rid="CR85">2014</xref>; Zeve et al. <xref ref-type="bibr" rid="CR97">2009</xref>).</p>
</sec>
<sec id="Sec7">
<title>Mechanisms Responsible for Regenerative Properties of ASCs</title>
<p>Several mechanisms can be responsible for the regenerative potential of ASCs. Some studies suggest that ASCs act via differentiation towards a specific cell type, thereby replacing defective cell populations in vivo. However, studies conducted on animal models, which allow for tracking ASCs in vivo do not confirm the aforementioned hypothesis (Gimble et al. <xref ref-type="bibr" rid="CR32">2012</xref>). With an exception of the “classic” mesenchymal phenotype (differentiation into adipocytes, osteoblasts, chondrocytes) none of the studies confirm the total and functional differentiation of mesenchymal-like cells. The phenotype of differentiated cells is mostly confirmed only by the expression of specific markers (Casteilla et al. <xref ref-type="bibr" rid="CR12">2011</xref>).</p>
<p>Some studies suggest that MSCs differentiation may lead to “intermediate two-phenotypic cells”, which show co-expression of specific cells and stromal markers without obtaining actual functionality (Rose et al. <xref ref-type="bibr" rid="CR72">2008</xref>). In such case, MSCs undergoing a specific differentiation would only express markers of “truly differentiated cells”, without demonstrating all of their functionality. Another unresolved problem is whether cells transdifferentiation is a result of their fusion which is considered to be the main mechanism for the formation of new functional cells (Utsunomiya et al. <xref ref-type="bibr" rid="CR86">2011</xref>). In a study conducted by Aurich et al. (<xref ref-type="bibr" rid="CR2">2009</xref>), there was no detected fusion of the implanted ASCs, differentiated towards hepatocytes, with hepatocytes of the host.</p>
<p>Another proposed mechanism of ASCs activity is the modulation stem cell niche of the host by stimulating the recruitment of endogenous stem cells to the damaged area and their commitment in the proper lineage. ASCs may be also a source of antioxidants, free radical scavengers and chaperone/heat shock proteins at the site of tissue damage. As a result of their actions, toxic substances are separated, removed and the surviving cells can restore their function (Friedenstein et al. <xref ref-type="bibr" rid="CR26">1968</xref>). Currently, many researchers believe that ASCs promote cell regeneration of tissues and organs, primarily through the release of cytokines and growth factors (Gimble et al. <xref ref-type="bibr" rid="CR32">2012</xref>).</p>
</sec>
<sec id="Sec8">
<title>Paracrine and Immunomodulatory Properties of ASCs</title>
<p>ASCs promote tissue regeneration by secreting cytokines and growth factors that stimulate restoration of normal tissue function or reduce its damage. Molecules secreted by ASCs have a positive effect on the central nervous system, immune system, heart, muscles and even the general vitality of cells (Salgado et al. <xref ref-type="bibr" rid="CR76">2010</xref>).</p>
<p>ASCs cell cytokine profile (Table <xref ref-type="table" rid="Tab3">3</xref>) comprises, inter alia, vascular endothelial growth factor (VEGF), granulocyte/macrophage colony-stimulating factor, cell-derived stromal factor 1-alpha, hepatocyte growth factor (HGF), transforming growth factor β, and fibroblast growth factor 2, which explains their impressive angiogenic properties and ability to induce tissue neovascularization (Gir et al. <xref ref-type="bibr" rid="CR33">2012</xref>; Sterodimas et al. <xref ref-type="bibr" rid="CR82">2010</xref>). Among the secreted anti-apoptotic factors it is worth to mention about insulin-like growth factor-1 (IGF-1), which, as was shown, may protect the cardiomyocytes against apoptosis (Sadat et al. <xref ref-type="bibr" rid="CR75">2007</xref>).<table-wrap id="Tab3"><label>Table 3</label><caption><p>ASCs cytokine profile</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Function</th><th align="left">Secreted protein</th></tr></thead><tbody><tr><td align="left">Immunomodulation</td><td align="left">TGF-β, HGF, PGE2, IL-6</td></tr><tr><td align="left">Vascularization</td><td align="left">VEGF, HGF, TGF-β2, FGF-2, bFGF, GM-CSF</td></tr><tr><td align="left">CUN regeneration</td><td align="left">BDNF, NGF, GDNF, IGF-1</td></tr><tr><td align="left">Hematopoiesis suport</td><td align="left">HGF, GM-CSF, IL-6,7,8,11, TNF-α</td></tr><tr><td align="left">Other</td><td align="left">Adiponectin, angiotensin, cathepsin D, retinol binding protein, CXCL12</td></tr></tbody></table><table-wrap-foot><p>Modified according to Salgado et al. (<xref ref-type="bibr" rid="CR76">2010</xref>)</p><p>Adipose-derived stem cells secrete several cytokines and growth factors that modulate immune response and facilitate regeneration of damaged tissues. These soluble mediators exhibit positive effect on central nervous system, heart, muscles and even the general vitality of cells</p><p>
<italic>GM-CSF</italic> granulocyte/macrophage colony-stimulating factor, <italic>TGF-β</italic> transforming growth factor β, <italic>FGF-2</italic> fibroblast growth factor 2, <italic>BDNF</italic> brain derived neurotrophic factor, <italic>GDNF</italic> glial derived neurotrophic factor, <italic>NGF</italic> nerve growth factor</p></table-wrap-foot></table-wrap>
</p>
<p>ASCs promote the regeneration of central nervous system cells and show a neuroprotective activity by secretion of brain derived neurotrophic factor, glial derived neurotrophic factor, nerve growth factor and IGF (Salgado et al. <xref ref-type="bibr" rid="CR76">2010</xref>). There is also evidence that growth factors, secreted by ASCs, stimulate the growth of fibroblasts and keratinocytes (Hong et al. <xref ref-type="bibr" rid="CR38">2013</xref>). In response to inflammatory stimuli, derived from adipose tissue, expression of angiogenic factors (VEGF, HGF, IGF-1), and hematopoietic/inflammatory factors (G-CSF, M-CSF, IL-6, TNF-α) in ASCs is increased (Kilroy et al. <xref ref-type="bibr" rid="CR45">2007</xref>).</p>
<p>ASCs are also immunoprivileged due to the lack of HLA-DR expression and the proliferation inhibition of activated allogeneic lymphocytes (Aust et al. <xref ref-type="bibr" rid="CR3">2004</xref>; Gonzalez-Rey et al. <xref ref-type="bibr" rid="CR34">2010</xref>; Mitchell et al. <xref ref-type="bibr" rid="CR56">2006</xref>). ASCs inhibit the generation of pro-inflammatory cytokines, stimulate the production of anti-inflammatory IL-10 cytokine and induce the formation of antigen-specific regulatory T cells (Gonzalez-Rey et al. <xref ref-type="bibr" rid="CR34">2010</xref>). The immunosuppressive properties of ASCs also result from the production of prostaglandin E2 and 2,3 dioxygenase indole (Gimble et al. <xref ref-type="bibr" rid="CR31">2011</xref>). These cells also protect against organ rejection and prevent from graft versus host disease after allogeneic stem cell transplantation (Yañez et al. <xref ref-type="bibr" rid="CR91">2006</xref>). Immunomodulatory properties have been confirmed both in vitro and in vivo (Baer <xref ref-type="bibr" rid="CR4">2014</xref>; Le Blanc et al. <xref ref-type="bibr" rid="CR48">2003</xref>; Nagaya et al. <xref ref-type="bibr" rid="CR59">2014</xref>; Patel et al. <xref ref-type="bibr" rid="CR64">2008</xref>).</p>
</sec>
<sec id="Sec9">
<title>Multilineage Differentiation Potential of ASCs</title>
<p>Literature provides abundant evidence concerning the in vitro multipotency of ASCs. Furthermore, this property is maintained during long-term culture (Baer and Geiger <xref ref-type="bibr" rid="CR5">2012</xref>). It is generally believed that ASCs origin from mesoderm, therefore, their potential to differentiate towards adipocytes, chondrocytes, osteoblasts and myocytes should be obvious and was confirmed in many studies (Mizuno <xref ref-type="bibr" rid="CR57">2009</xref>). Induction of ASCs differentiation in vitro occurs mainly by culturing cells in culture media supplemented with specific growth factors (Baer and Geiger <xref ref-type="bibr" rid="CR5">2012</xref>). Subsequent studies have expanded the potential of adipose derived stem cells on the ability to differentiate into non-mesodermal cells, i.e. ecto- and endodermal (Mizuno <xref ref-type="bibr" rid="CR57">2009</xref>).</p>
<p>ASCs support hematopoiesis and angiogenesis, also their differentiation potential toward endothelial cells and their participation in the blood vessels formation is confirmed in literature (Sood et al. <xref ref-type="bibr" rid="CR81">2011</xref>). Aforementioned cells cultured in vitro on the matrigel quickly and easily form a vascular-like structure adopting the endothelium function (Cao et al. <xref ref-type="bibr" rid="CR11">2005</xref>; Sood et al. <xref ref-type="bibr" rid="CR81">2011</xref>). Formation of the functional vascularization by these cells was confirmed in vivo in a number of models such as: myocardial infarction, regeneration of epithelium and nerve tissue (Baptista et al. <xref ref-type="bibr" rid="CR7">2015</xref>).</p>
<p>Some reports about the possibility of ASCs differentiation into the insulin-producing β cells, glucagon and somatostatin appeared in literature (Colazzo et al. <xref ref-type="bibr" rid="CR14">2010</xref>). ASCs were able to differentiate towards hepatocyte-like cells, expressing albumin and α-fetoprotein, LDL uptake and urea production (Lindroos et al. <xref ref-type="bibr" rid="CR54">2011</xref>). In vivo, hepatocyte-like cells derived from ASCs reconstitute the function of hepatocytes (Timper et al. <xref ref-type="bibr" rid="CR83">2006</xref>).</p>
<p>Findings concerning the ASCs participation in the formation of functional neurons are contradictory. Some studies confirm their differentiation into neuronal cells, both morphologically and functionally (Seo et al. <xref ref-type="bibr" rid="CR79">2005</xref>). Many researchers see hope in treatment of nerve injuries using ASCs thus, confirming their participation in neuronal regeneration (Mizuno et al. <xref ref-type="bibr" rid="CR58">2012</xref>; Khalifian et al. <xref ref-type="bibr" rid="CR44">2015</xref>; Zack-Williams et al. <xref ref-type="bibr" rid="CR95">2015</xref>).</p>
<p>However, in most cases, the analysis of ASCs multipotency is based, on morphology and surface marker expression of differentiated cells in vitro (Di Summa et al. <xref ref-type="bibr" rid="CR20">2010</xref>). Only a hand full of studies evaluate the differentiation effect in terms of functionality, such as the myocytes contractility (Johal et al. <xref ref-type="bibr" rid="CR41">2015</xref>; Rangappa et al. <xref ref-type="bibr" rid="CR69">2003</xref>). Currently the main focus of researchers regarding the potential of in vivo transplanted ASCs lies in the context of tissue engineering and regenerative medicine (Table <xref ref-type="table" rid="Tab4">4</xref>) (Di Summa et al. <xref ref-type="bibr" rid="CR20">2010</xref>).<table-wrap id="Tab4"><label>Table 4</label><caption><p>In vitro and in vivo multipotency of ASCs</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"></th><th align="left">Differentiation inducing factors</th><th align="left">Differentiation in vitro</th><th align="left">Differentiation in vivo</th><th align="left">Examples</th></tr></thead><tbody><tr><td align="left">White adipocytes/adipose tissue</td><td align="left">Insulin, IBMX, dexamethasone, indometacin, rosiglitazone, thiazolidinedione</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">Gelatin matrix + preinduced human ASCs, subcutaneous, mice lacking thymus<break></break>Fibrin glue + GFP + murine visceral ASCs, subcutaneous, mouse</td></tr><tr><td align="left">Osteoblasts/bone</td><td align="left">25-Dihydroxyvitamin D3, glycerophosphate, ascorbic acid, bone morphogenetic protein-2, valproic acid</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">PLGA scaffold + human ASCs induced toward osteoblasts, skull damage, rats lackingthymus<break></break>PLA scaffold + rat ASCs induced toward osteoblasts, palate damage, rats</td></tr><tr><td align="left">Chondrocytes/cartilage</td><td align="left">FGF, TGF-β, dexamethasone, IGH, bone morphogenetic protein-6, ascorbic acid, insulin</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">PLGA scaffold + induced with TGF-β1 human ASCs, subcutaneous, mice lacking thymus<break></break>Fibrin glue + rabbit ASCs, cartilage damage, rabbits</td></tr><tr><td align="left">Skeletal myocytes</td><td align="left">Dexamethasone, horse serum, co-culture with primary myoblasts or myoblast cell lines</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">Preinduced human ASCs + mouse model of muscular dystrophy</td></tr><tr><td align="left">Cardiomyocytes</td><td align="left">Interleukin-3, interleukin-6, transferrin, VEGF, 5-azacytidine</td><td align="left">Yes/No</td><td align="left">Yes</td><td align="left">ASCs + injection into the myocardial, infarction model, rats lacking thymus<break></break>Cardiomyoblasts derived from human ASCs + porcine model of myocardial infarction</td></tr><tr><td align="left">Smooth muscle<break></break>myocytes</td><td align="left">Heparin, TGF-β1, bone morphogenetic protein-4</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">ASCs co-culture with human bladder smooth muscle + injection into the bladder, mice lacking thymus<break></break>Rats ASCs, model of stress urinary incontinence, rats</td></tr><tr><td align="left">Endothelial cells</td><td align="left">EGF, bFGF, hydrocortisone</td><td align="left">Yes/no</td><td align="left">Yes</td><td align="left">Human ASCs + model of hindlimb ischemia, mice<break></break>Rats ASCs + model of ischemia–reperfusion injury, rats, intravenous administration</td></tr><tr><td align="left">Nerve cells</td><td align="left">Valproic acid, insulin, hydrocortisone, EGF, FGF</td><td align="left">Yes/no</td><td align="left">Yes</td><td align="left">Schwann cells derived from ASCs + rat spinal cord injury, rats<break></break>ASCs induced toward neurogenesis + rat focal brain injury, rats</td></tr><tr><td align="left">Hepatocytes</td><td align="left">HGF, oncostatin, dimethylsulfoxide</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">Human ASCs + partial hepatectomy, mice lacking thymus, intravenous<break></break>Human ASCs + CCl4-induced liver injury, mice lacking thymic</td></tr><tr><td align="left">β cells pancreatic islet</td><td align="left">Nicotinamide, activin-A, exendin-4, HGF, pentagastrin, glucose</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">Rats ASCs + Pdx1 transduction, streptozotocin-induced diabetes, rats</td></tr></tbody></table><table-wrap-foot><p>Modified according to Cawthorn et al. (<xref ref-type="bibr" rid="CR13">2012</xref>), Hoekstra (<xref ref-type="bibr" rid="CR37">2011</xref>), Yarak and Okamoto (<xref ref-type="bibr" rid="CR92">2010</xref>) and Zuk (<xref ref-type="bibr" rid="CR100">2013</xref>)</p><p>Adipose derived stem cells have potential to differentiate into cells of mesodermal and non-mesodermal origin. When maintained under optimal growth conditions they have been shown to be multipotent, capable of differentiating down the adipogenic, osteogenic and chondrogenic lineages. Differentiation into other cell types, i.e. cardiomyocytes or endothelial cells was also confirmed</p></table-wrap-foot></table-wrap>
</p>
</sec>
<sec id="Sec10">
<title>Clinical Studies with ASCs</title>
<p>In clinical applications, ASCs were used for the first time in year 2004, when they were implanted together with a bone fragment, fibrin glue and a biodegradable scaffold to regenerate a large bone defect in the skull of 7-year-old girl (Hoekstra <xref ref-type="bibr" rid="CR37">2011</xref>). Currently, the quantity of proposals for the use of these cells in tissue repair and regeneration is impressive. Number of clinical trials evaluating the efficacy and safety of ASCs in tissue reconstruction and regeneration increases significantly each year.</p>
<p>According to the clinical trials database (ClinicalTrials.gov database <xref ref-type="bibr" rid="CR35">2015</xref>) there are 122 studies currently registered as using adipose derived stem cells. These studies include treatment of: diabetes, liver cirrhosis, fistulas, cardiovascular disease, limb ischemia, amyotrophic lateral sclerosis, lipodystrophy, graft versus host disease, Crohn’s disease, atherosclerosis, soft-tissue augmentation and bone defects (Table <xref ref-type="table" rid="Tab5">5</xref>) (Lendeckel et al. <xref ref-type="bibr" rid="CR49">2004</xref>). As Kim and Jeong (<xref ref-type="bibr" rid="CR46">2014</xref>) stated in his review, ACSs are more liberally used in clinical treatment in Korea and Japan for plastic surgery and esthetic treatments because of legal reasons. Most of currently conducted research is at its early stages (Table <xref ref-type="table" rid="Tab6">6</xref>), and the study population do not not exceed 100 patients. A large amount of studies contains only a descriptions of cases rather than randomized trials, without any control groups. Five studies were terminated (Table <xref ref-type="table" rid="Tab7">7</xref>), including the cirrhosis treatment due to a lack of efficacy.<table-wrap id="Tab5"><label>Table 5</label><caption><p>Clinical trials with the use of ASCs</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Indication</th><th align="left">Number of trials</th></tr></thead><tbody><tr><td align="left" colspan="2">Endocrine system</td></tr><tr><td align="left"> Diabetes and its complications</td><td align="char" char=".">6</td></tr><tr><td align="left" colspan="2">Gastrointestinal and urogenital tract</td></tr><tr><td align="left"> Crohn’s disease/fistula/faecal incontinence</td><td align="char" char=".">19</td></tr><tr><td align="left"> Urinary incontinence</td><td align="char" char=".">3</td></tr><tr><td align="left"> Renal failure</td><td align="char" char=".">1</td></tr><tr><td align="left"> Liver failure</td><td align="char" char=".">3</td></tr><tr><td align="left"> Ovaries failure</td><td align="char" char=".">1</td></tr><tr><td align="left"> Eractile dysfunction/urethral structure</td><td align="char" char=".">4</td></tr><tr><td align="left" colspan="2">Ischemia</td></tr><tr><td align="left"> Angiogenesis/Burger disease/limb ischemia</td><td align="char" char=".">12</td></tr><tr><td align="left"> Vascular occlusive disease of the kidney</td><td align="char" char=".">1</td></tr><tr><td align="left"> Myocardial infarction</td><td align="char" char=".">4</td></tr><tr><td align="left" colspan="2">Hard and soft tissues</td></tr><tr><td align="left"> Arthritis/bone/cartilage</td><td align="char" char=".">24</td></tr><tr><td align="left"> Lipodystrophy</td><td align="char" char=".">2</td></tr><tr><td align="left"> Romberg disease</td><td align="char" char=".">1</td></tr><tr><td align="left"> Cosmetics reconstruction</td><td align="char" char=".">7</td></tr><tr><td align="left" colspan="2">Other</td></tr><tr><td align="left"> Central nervous system/keratopathy/multiple sclerosis/Parkinson’s disease/stroke</td><td align="char" char=".">11</td></tr><tr><td align="left"> GvHD</td><td align="char" char=".">1</td></tr><tr><td align="left"> Spinal cord injury</td><td align="char" char=".">4</td></tr><tr><td align="left"> Autism</td><td align="char" char=".">1</td></tr><tr><td align="left"> Heart failure</td><td align="char" char=".">4</td></tr><tr><td align="left"> Frailty syndrome</td><td align="char" char=".">1</td></tr><tr><td align="left"> Chronic obstructive pulmonary disease/pulmonary fibrosis</td><td align="char" char=".">5</td></tr><tr><td align="left"> Dry macular degeneration/retinal degeneration</td><td align="char" char=".">2</td></tr><tr><td align="left"> Pain</td><td align="char" char=".">2</td></tr><tr><td align="left"> Acute respiratory distress syndrome</td><td align="char" char=".">1</td></tr><tr><td align="left"> Sepsis</td><td align="char" char=".">1</td></tr></tbody></table><table-wrap-foot><p>On the basis of (ClinicalTrials.gov database <xref ref-type="bibr" rid="CR35">2015</xref>)</p><p>Adipose derived stem cells are currently used in several clinical trials. Most of them concern gastrointestinal and urogenital tract pathologies and cartilage and bone degeneration</p><p>
<italic>GvHD</italic> graft versus host disease</p></table-wrap-foot></table-wrap>
<table-wrap id="Tab6"><label>Table 6</label><caption><p>Phase of clinical trials with the use of ASCs</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Study chase</th><th align="left">Number of the studiem</th></tr></thead><tbody><tr><td align="left">0</td><td align="char" char=".">2</td></tr><tr><td align="left">I</td><td align="char" char=".">23</td></tr><tr><td align="left">II</td><td align="char" char=".">18</td></tr><tr><td align="left">I/II</td><td align="char" char=".">58</td></tr><tr><td align="left">III</td><td align="char" char=".">5</td></tr><tr><td align="left">II/III</td><td align="char" char=".">1</td></tr><tr><td align="left">IV</td><td align="char" char=".">2</td></tr><tr><td align="left">Unknown</td><td align="char" char=".">13</td></tr></tbody></table><table-wrap-foot><p>On the basis of (ClinicalTrials.gov database <xref ref-type="bibr" rid="CR35">2015</xref>)</p><p>Most of ongoing clinical trials evaluating regenerative potential of adipose-derives stem cells are at early stage of the study. Their main goal is to assess stem cell therapy safety within small groups of patients and identify its side effects</p></table-wrap-foot></table-wrap>
<table-wrap id="Tab7"><label>Table 7</label><caption><p>Status of clinical trials with the use of ASCs</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Study status</th><th align="left">Number of trias</th></tr></thead><tbody><tr><td align="left">Not recruiting</td><td align="char" char=".">32</td></tr><tr><td align="left">Recruiting</td><td align="char" char=".">60</td></tr><tr><td align="left">Finished</td><td align="char" char=".">25</td></tr><tr><td align="left">Interrupted</td><td align="char" char=".">5</td></tr></tbody></table><table-wrap-foot><p>On the basis of (ClinicalTrials.gov database <xref ref-type="bibr" rid="CR35">2015</xref>)</p><p>Majority of clinical trials evaluating efficacy of stem cell therapy are at early stage of patient recruitment. Only 20 % were finished. Some studies were interrupted including cirrhosis treatment due to lack of efficacy</p></table-wrap-foot></table-wrap>
</p>
<p>Clinical studies are generally based on the use of the whole SVF, isolated ASCs (alone or in combination with biomaterials) or fat tissue itself enriched with ASCs. Studies differ in the ASCs type used, some use autologous ASCs, other allogenic ones. There is also a significant difference in density of transplanted cells and the route of their administration. It is also worth to note that some studies are based on the immunomodulatory and angiogenic properties of ASCs. These studies concern the treatment of autoimmune diseases, ischaemia or diabetic wounds of lower limbs. Researches based on ASCs differentiation, include treatment of degenerative arthritis, cardiac or spinal injury.</p>
</sec>
<sec id="Sec11">
<title>Why the Cell-Based Therapies Can Fail?</title>
<p>The development of tissue engineering, regenerative medicine and cell based therapies will surely prevent many currently incurable diseases. However, before achieving an efficient clinical application it is necessary to overcome many technical limitations. There are certainly a lot of questions that should be addressed at preclinical and clinical levels, e.g. spontaneous differentiation of stem cells into target cells or the problem of cell migration and homing mechanisms. We have to consider adipose tissue as an effective regeneration tool, isolation of a homogenous stem cell fraction is crucial. Recently, a whole adipose tissue-derived SVF became popular in clinical applications, especially in one-step surgeries in the field of orthopedics. However, there is little data concerning a full characterization of this fraction, which is very heterogeneous. It contains the mixture of endothelial cells, smooth muscle cells, fibroblast, pericytes and mast cells. In such therapies we transplant the whole microenvironment of stem cells rather than just stem cells alone. Therefore it is not surprising that grafts with the SVF fraction give promising results. However, we need to understand the mechanism of action before introducing it to common clinical practice. There is a huge need to answer which factors give and support the best therapeutic effect, especially in long-term basis. Further questions arise, whether the grafted stem cells can maintain their undifferentiated state or do they differentiate. This last issue is very important in the light of a possibility of undesirable ASCs differentiation and their interaction with tumor cells. It has been reported that these cells, in some cases, may favor tumor growth (Prantl et al. <xref ref-type="bibr" rid="CR67">2010</xref>), or quite the opposite, inhibiting the the proliferation of cancer cells (Cousin et al. <xref ref-type="bibr" rid="CR15">2009</xref>). Some studies, carried out on primary tumor cells, conclude that ASCs can induce tumor cell growth in the presence of active tumor cells but not mitoticly inactive ones (Zimmerlin et al. <xref ref-type="bibr" rid="CR99">2011</xref>). Eterno et al. (<xref ref-type="bibr" rid="CR21">2014</xref>) showed that ASCs may support the proliferation of breast cancer cells through the activation of HGF/c-Met/beta-catenin axis, which is very important in the light of increased breast cancer recurrence rates after fat grafts. These contradictory results generate the need for more detailed molecular characterization of adipose derived stem cells. Unfortunately, information relating to undesirable ASCs differentiation is very limited. The only described case regards the appearance of cysts and microcalcifications in 4 of 70 patients undergoing breast reconstruction using lipoaspiration enriched by SVF (Yoshimura et al. <xref ref-type="bibr" rid="CR94">2008</xref>). This may be due to the fact that such a phenomenon is rare or has not been fully investigated. Further studies are necessary to elucidate the mechanism of stem cell transformation, which will greatly contribute to cell fate regulation and inhibition of oncogenesis in different organs. Summarizing, it is very important to be aware that stem cell therapies, despite the great hope, also poses weakness and limitation. We have to isolate and culture immune-specific and homogenous stem cell populations, improve the efficiency of differentiation into target cells, establish an optimal stage of transplantation and improve the post-transplantation migration and regeneration rate (Bajek et al. <xref ref-type="bibr" rid="CR6">2014</xref>; Lim et al. <xref ref-type="bibr" rid="CR51">2011</xref>).</p>
</sec>
<sec id="Sec12">
<title>Conclusion</title>
<p>Although, there are dozens of clinical studies using ASCs, there is an apparent lack of reports that unambiguously confirm the effectiveness of this type of cell therapy. Still, many important questions remain before effective clinical applications of ASCs therapies for humans arise. Nevertheless, the clinical use of ASCs is undeniably very exciting and draws a lot of attention.</p>
</sec>
</body>
<back>
<fn-group>
<fn>
<p>A. Bajek and N. Gurtowska contributed equally to this work.</p>
</fn>
</fn-group>
<notes notes-type="COI-statement">
<title>Compliance with ethical standards</title>
<sec id="FPar1">
<title>Conflict of interest</title>
<p>The authors declare that they have no conflict of interest.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Astori</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Vignati</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Bardelli</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>“In vitro” and multicolor phenotypic characterization of cell subpopulations identified in fresh human adipose tissue stromal vascular fraction and in the derived mesenchymal stem cells</article-title>
<source/>J Transl Med
          <year>2007</year>
<volume>5</volume>
<fpage>55</fpage>
<pub-id pub-id-type="doi">10.1186/1479-5876-5-55</pub-id>
<pub-id pub-id-type="pmid">17974012</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aurich</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sgodda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kaltwasser</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo</article-title>
<source/>Gut
          <year>2009</year>
<volume>58</volume>
<fpage>570</fpage>
<lpage>581</lpage>
<pub-id pub-id-type="doi">10.1136/gut.2008.154880</pub-id>
<pub-id pub-id-type="pmid">19022918</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aust</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Devlin</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Foster</surname>
<given-names>SJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Yield of human adipose-derived adult stem cells from liposuction aspirates</article-title>
<source/>Cytotherapy
          <year>2004</year>
<volume>6</volume>
<fpage>7</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="doi">10.1080/14653240310004539</pub-id>
<pub-id pub-id-type="pmid">14985162</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baer</surname>
<given-names>PC</given-names>
</name>
</person-group>
<article-title>Adipose-derived mesenchymal stromal/stem cells: an update on their phenotype in vivo and in vitro</article-title>
<source/>World J Stem Cells
          <year>2014</year>
<volume>6</volume>
<fpage>256</fpage>
<lpage>265</lpage>
<pub-id pub-id-type="doi">10.4252/wjsc.v6.i3.256</pub-id>
<pub-id pub-id-type="pmid">25126376</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baer</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Geiger</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>adipose-derived mesenchymal stromal/stem cells: tissue localization, characterization, and heterogenity</article-title>
<source/>Stem Cells Int
          <year>2012</year>
<volume>2012</volume>
<fpage>812693</fpage>
<pub-id pub-id-type="doi">10.1155/2012/812693</pub-id>
<pub-id pub-id-type="pmid">22577397</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bajek</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Olkowska</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gurtowska</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human amniotic fluid derived stem cells: a unique source for regenerative medicine</article-title>
<source/>Expert Opin Biol Ther
          <year>2014</year>
<volume>14</volume>
<fpage>831</fpage>
<lpage>839</lpage>
<pub-id pub-id-type="doi">10.1517/14712598.2014.898749</pub-id>
<pub-id pub-id-type="pmid">24655038</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baptista</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Borojevic</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Obesity and weight loss could alter the properties of adipose stem cells?</article-title>
<source/>World J Stem Cells
          <year>2015</year>
<volume>7</volume>
<fpage>165</fpage>
<lpage>173</lpage>
<pub-id pub-id-type="doi">10.4252/wjsc.v7.i1.165</pub-id>
<pub-id pub-id-type="pmid">25621116</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bear</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Kuci</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Krause</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Comprehensive phenotype characterization of human adipose-derived stromal/stem cells and their subsets by a high throughput technology</article-title>
<source/>Stem Cells Dev
          <year>2013</year>
<volume>22</volume>
<fpage>330</fpage>
<lpage>339</lpage>
<pub-id pub-id-type="doi">10.1089/scd.2012.0346</pub-id>
<pub-id pub-id-type="pmid">22920587</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brzoska</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Geiger</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Gauer</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Epithelial differentiation of human adipose tissue-derived adult stem cells</article-title>
<source/>Biochem Biophys Res Commun
          <year>2005</year>
<volume>330</volume>
<fpage>142</fpage>
<lpage>150</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2005.02.141</pub-id>
<pub-id pub-id-type="pmid">15781243</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bunnell</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Flaat</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gagliardi</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Adipose-derived stem cells: isolation, expansion and differentiation</article-title>
<source/>Methods
          <year>2008</year>
<volume>45</volume>
<fpage>115</fpage>
<lpage>120</lpage>
<pub-id pub-id-type="doi">10.1016/j.ymeth.2008.03.006</pub-id>
<pub-id pub-id-type="pmid">18593609</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo</article-title>
<source/>Biochem Biophys Res Commun
          <year>2005</year>
<volume>332</volume>
<fpage>370</fpage>
<lpage>379</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2005.04.135</pub-id>
<pub-id pub-id-type="pmid">15896706</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Casteilla</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Planat-Benard</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Laharrague</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Adipose-derived stromal cells: their identity and uses in clinical, trials, an update</article-title>
<source/>World J Stem Cells
          <year>2011</year>
<volume>3</volume>
<fpage>25</fpage>
<lpage>33</lpage>
<pub-id pub-id-type="doi">10.4252/wjsc.v3.i4.25</pub-id>
<pub-id pub-id-type="pmid">21607134</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cawthorn</surname>
<given-names>WP</given-names>
</name>
<name>
<surname>Scheller</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>MacDougland</surname>
<given-names>OA</given-names>
</name>
</person-group>
<article-title>Adipose tissue stem cells meet preadipocyte commitment: going back to the future</article-title>
<source/>J Lipid Res
          <year>2012</year>
<volume>53</volume>
<fpage>227</fpage>
<lpage>246</lpage>
<pub-id pub-id-type="doi">10.1194/jlr.R021089</pub-id>
<pub-id pub-id-type="pmid">22140268</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Colazzo</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Chester</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>PM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Induction of mesenchymal to endothelial transformation of adipose-derived stem cells</article-title>
<source/>J Heart Valve Dis
          <year>2010</year>
<volume>19</volume>
<fpage>736</fpage>
<lpage>744</lpage>
<pub-id pub-id-type="pmid">21214098</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cousin</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ravet</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Poglio</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo</article-title>
<source/>PLoS One
          <year>2009</year>
<volume>4</volume>
<fpage>e6278</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0006278</pub-id>
<pub-id pub-id-type="pmid">19609435</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crandall</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Hausman</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Kral</surname>
<given-names>JG</given-names>
</name>
</person-group>
<article-title>A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives</article-title>
<source/>Microcirculation
          <year>1997</year>
<volume>4</volume>
<fpage>211</fpage>
<lpage>232</lpage>
<pub-id pub-id-type="doi">10.3109/10739689709146786</pub-id>
<pub-id pub-id-type="pmid">9219215</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crisan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yap</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Casteilla</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A perivascular origin for mesenchymal stem cells in multiple human organs</article-title>
<source/>Cell Stem Cell
          <year>2008</year>
<volume>3</volume>
<fpage>301</fpage>
<lpage>313</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2008.07.003</pub-id>
<pub-id pub-id-type="pmid">18786417</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dahl</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Duggal</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Coulston</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genetic and epigenetic instability of human bone marrow mesenchymal stem cells expanded in autologous serum or fetal bovine serum</article-title>
<source/>Int J Dev Biol
          <year>2008</year>
<volume>52</volume>
<fpage>1033</fpage>
<lpage>1042</lpage>
<pub-id pub-id-type="doi">10.1387/ijdb.082663jd</pub-id>
<pub-id pub-id-type="pmid">18956336</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Ugarte</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Morizono</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Elbarbary</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Comparison of multi-lineage cells from human adipose tissue and bone marrow</article-title>
<source/>Cells Tissues Organs
          <year>2003</year>
<volume>174</volume>
<fpage>101</fpage>
<lpage>109</lpage>
<pub-id pub-id-type="doi">10.1159/000071150</pub-id>
<pub-id pub-id-type="pmid">12835573</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Summa</surname>
<given-names>PG</given-names>
</name>
<name>
<surname>Kingham</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Raffoul</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Adipose-derived stem cells enhance peripheral nerve regeneration</article-title>
<source/>J Plast Reconstr Aesthet Surg
          <year>2010</year>
<volume>63</volume>
<fpage>1544</fpage>
<lpage>1552</lpage>
<pub-id pub-id-type="doi">10.1016/j.bjps.2009.09.012</pub-id>
<pub-id pub-id-type="pmid">19828391</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eterno</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Zambelli</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pavesi</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Adipose-derived mesenchymal stem cells (ASCs) may favour breast cancer recurrence via HGF/c-Met signaling</article-title>
<source/>Oncotarget
          <year>2014</year>
<volume>5</volume>
<fpage>613</fpage>
<lpage>633</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.1359</pub-id>
<pub-id pub-id-type="pmid">24327602</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eto</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Suga</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characterization of structure and cellular components of aspirated and excised adipose tissue</article-title>
<source/>Plast Reconstr Surg
          <year>2009</year>
<volume>124</volume>
<fpage>1087</fpage>
<lpage>1097</lpage>
<pub-id pub-id-type="doi">10.1097/PRS.0b013e3181b5a3f1</pub-id>
<pub-id pub-id-type="pmid">19935292</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mantesso</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sharpe</surname>
<given-names>PT</given-names>
</name>
</person-group>
<article-title>Perivascular cells as mesenchymal stem cells</article-title>
<source/>Expert Opin Biol Ther
          <year>2010</year>
<volume>10</volume>
<fpage>1441</fpage>
<lpage>1451</lpage>
<pub-id pub-id-type="doi">10.1517/14712598.2010.517191</pub-id>
<pub-id pub-id-type="pmid">20836622</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fraser</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Wulur</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Alfonso</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fat tissue: an underappreciated source of stem cells for biotechnology</article-title>
<source/>Trends Biotechnol
          <year>2006</year>
<volume>24</volume>
<fpage>150</fpage>
<lpage>154</lpage>
<pub-id pub-id-type="doi">10.1016/j.tibtech.2006.01.010</pub-id>
<pub-id pub-id-type="pmid">16488036</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fraster</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Wulur</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Alfonso</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Differences in stem and progenitor cell yield in different subcutaneous adipose tissue depots</article-title>
<source/>Cytotherapy
          <year>2007</year>
<volume>9</volume>
<fpage>459</fpage>
<lpage>467</lpage>
<pub-id pub-id-type="doi">10.1080/14653240701358460</pub-id>
<pub-id pub-id-type="pmid">17786607</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Friedenstein</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Petrakova</surname>
<given-names>KV</given-names>
</name>
<name>
<surname>Kurolesova</surname>
<given-names>AI</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues</article-title>
<source/>Transplantation
          <year>1968</year>
<volume>6</volume>
<fpage>230</fpage>
<lpage>247</lpage>
<pub-id pub-id-type="doi">10.1097/00007890-196803000-00009</pub-id>
<pub-id pub-id-type="pmid">5654088</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fuchs</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Tumbar</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Guasch</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Socializing with the neighbors: stem cells and their niche</article-title>
<source/>Cell
          <year>2004</year>
<volume>116</volume>
<fpage>769</fpage>
<lpage>778</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(04)00255-7</pub-id>
<pub-id pub-id-type="pmid">15035980</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Furstenberg</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lachowicz</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Stachoń</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Different sides of the adipose tissue and of dietary fat</article-title>
<source/>Kosmos
          <year>2010</year>
<volume>59</volume>
<fpage>315</fpage>
<lpage>326</lpage>
</element-citation>
</ref>
<ref id="CR29">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gimble</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Katz</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Bunnell</surname>
<given-names>BA</given-names>
</name>
</person-group>
<article-title>Adipose-derived stem cells for regenerative medicine</article-title>
<source/>Circ Res
          <year>2007</year>
<volume>100</volume>
<fpage>1249</fpage>
<lpage>1260</lpage>
<pub-id pub-id-type="doi">10.1161/01.RES.0000265074.83288.09</pub-id>
<pub-id pub-id-type="pmid">17495232</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gimble</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Guilak</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Bunnell</surname>
<given-names>BA</given-names>
</name>
</person-group>
<article-title>Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells</article-title>
<source/>Stem Cell Res Ther
          <year>2010</year>
<volume>1</volume>
<fpage>19</fpage>
<pub-id pub-id-type="doi">10.1186/scrt19</pub-id>
<pub-id pub-id-type="pmid">20587076</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gimble</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Grayson</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Guilak</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Adipose tissue as a stem cell source for musculoskeletal regeneration</article-title>
<source/>Front Biosci (Schol Ed)
          <year>2011</year>
<volume>3</volume>
<fpage>69</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.2741/s133</pub-id>
<pub-id pub-id-type="pmid">21196358</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gimble</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Bunnell</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Guilak</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Human adipose-derived cells: an update on the transition to clinical translation</article-title>
<source/>Regen Med
          <year>2012</year>
<volume>7</volume>
<fpage>225</fpage>
<lpage>235</lpage>
<pub-id pub-id-type="doi">10.2217/rme.11.119</pub-id>
<pub-id pub-id-type="pmid">22397611</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gir</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Oni</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>SA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human adipose stem cells: current clinical applications</article-title>
<source/>Plast Reconstr Surg
          <year>2012</year>
<volume>129</volume>
<fpage>1277</fpage>
<lpage>1290</lpage>
<pub-id pub-id-type="doi">10.1097/PRS.0b013e31824ecae6</pub-id>
<pub-id pub-id-type="pmid">22634645</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonzalez-Rey</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Varela</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis</article-title>
<source/>Ann Rheum Dis
          <year>2010</year>
<volume>69</volume>
<fpage>241</fpage>
<lpage>248</lpage>
<pub-id pub-id-type="doi">10.1136/ard.2008.101881</pub-id>
<pub-id pub-id-type="pmid">19124525</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<mixed-citation publication-type="other">ClinicalTrials.gov database (2015) <ext-link ext-link-type="uri" xlink:href="http://clinicaltrials.gov/ct2/results%3fterm%3dadipose%2bstem%2bcells%26Search%3dSearch">http://clinicaltrials.gov/ct2/results?term=adipose+stem+cells&amp;Search=Search</ext-link>. Accessed 5 Feb 2015</mixed-citation>
</ref>
<ref id="CR36">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heymans</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Castus</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Grandjean</surname>
<given-names>FX</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Liposuction: review of the techniques, innovations and applications</article-title>
<source/>Acta Chir Belg
          <year>2006</year>
<volume>106</volume>
<fpage>647</fpage>
<lpage>653</lpage>
<pub-id pub-id-type="doi">10.1080/00015458.2006.11679973</pub-id>
<pub-id pub-id-type="pmid">17290687</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoekstra</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Prospering on the fat of the land: adipose-derived stem cells as an industrially-viable resource for regenerative treatment</article-title>
<source/>Basic Biotechnol
          <year>2011</year>
<volume>7</volume>
<fpage>24</fpage>
<lpage>30</lpage>
</element-citation>
</ref>
<ref id="CR38">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hong</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>S-X</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Topically delivered adipose derived stem cells show an activated-fibroblast phenotype and enhance granulation tissue formation in skin wounds</article-title>
<source/>PLoS One
          <year>2013</year>
<volume>8</volume>
<fpage>e55640</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0055640</pub-id>
<pub-id pub-id-type="pmid">23383253</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Izadpanah</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Trygg</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue</article-title>
<source/>J Cell Biochem
          <year>2006</year>
<volume>99</volume>
<fpage>1285</fpage>
<lpage>1297</lpage>
<pub-id pub-id-type="doi">10.1002/jcb.20904</pub-id>
<pub-id pub-id-type="pmid">16795045</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeon</surname>
<given-names>BG</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>EJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characterization and comparison of telomere length, telomerase and reverse transcriptase activity and gene expression in human mesenchymal stem cells and cancer cells of various origins</article-title>
<source/>Cell Tissue Res
          <year>2011</year>
<volume>345</volume>
<fpage>149</fpage>
<lpage>161</lpage>
<pub-id pub-id-type="doi">10.1007/s00441-011-1191-9</pub-id>
<pub-id pub-id-type="pmid">21638208</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johal</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Lees</surname>
<given-names>VC</given-names>
</name>
<name>
<surname>Reid</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>Adipose-derived stem cells: selecting for translational success</article-title>
<source/>Regen Med
          <year>2015</year>
<volume>10</volume>
<fpage>79</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="doi">10.2217/rme.14.72</pub-id>
<pub-id pub-id-type="pmid">25562354</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Katz</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Llull</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hedrick</surname>
<given-names>MH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Emerging approaches to the tissue engineering of fat</article-title>
<source/>Clin Plast Surg
          <year>1999</year>
<volume>26</volume>
<fpage>587</fpage>
<lpage>603</lpage>
<pub-id pub-id-type="pmid">10553215</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Katz</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Hedrick</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Llull</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A novel device for the simple and efficient refinement of liposuctioned tissue</article-title>
<source/>Plast Reconstr Surg
          <year>2001</year>
<volume>107</volume>
<fpage>595</fpage>
<lpage>597</lpage>
<pub-id pub-id-type="doi">10.1097/00006534-200102000-00047</pub-id>
<pub-id pub-id-type="pmid">11214080</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khalifian</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sarhane</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Tammia</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Stem cell-based approaches to improve nerve regeneration: potential implications for reconstructive transplantation?</article-title>
<source/>Arch Immunol Ther Exp
          <year>2015</year>
<volume>63</volume>
<fpage>15</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="doi">10.1007/s00005-014-0323-9</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kilroy</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Foster</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors</article-title>
<source/>J Cell Physiol
          <year>2007</year>
<volume>212</volume>
<fpage>702</fpage>
<lpage>709</lpage>
<pub-id pub-id-type="doi">10.1002/jcp.21068</pub-id>
<pub-id pub-id-type="pmid">17477371</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Jeong</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>Clinical application of adipose stem cells in plastic surgery</article-title>
<source/>J Korean Med Sci
          <year>2014</year>
<volume>29</volume>
<fpage>462</fpage>
<lpage>467</lpage>
<pub-id pub-id-type="doi">10.3346/jkms.2014.29.4.462</pub-id>
<pub-id pub-id-type="pmid">24753692</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuroda</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kitada</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wakao</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Bone marrow mesenchymal cells: how do they contribute to tissue repair and they really stem cells?</article-title>
<source/>Arch Immunol Ther Exp
          <year>2011</year>
<volume>59</volume>
<fpage>369</fpage>
<lpage>378</lpage>
<pub-id pub-id-type="doi">10.1007/s00005-011-0139-9</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le Blanc</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tammik</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sundberg</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex</article-title>
<source/>Scand J Immunol
          <year>2003</year>
<volume>57</volume>
<fpage>11</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="doi">10.1046/j.1365-3083.2003.01176.x</pub-id>
<pub-id pub-id-type="pmid">12542793</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lendeckel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jodicke</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Christophis</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Autologous stem cells (adipose) and fibrin glue used to treat wide-spread traumatic calvarial defects: case report</article-title>
<source/>J Craniomaxillofac Surg
          <year>2004</year>
<volume>32</volume>
<fpage>370</fpage>
<lpage>373</lpage>
<pub-id pub-id-type="doi">10.1016/j.jcms.2004.06.002</pub-id>
<pub-id pub-id-type="pmid">15555520</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leto Barone</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Khalifian</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>WP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Immunomodulatory effects of adipose-derived stem cells: fact or fiction?</article-title>
<source/>Biomed Res Int
          <year>2013</year>
<volume>2013</volume>
<fpage>383685</fpage>
<pub-id pub-id-type="doi">10.1155/2013/383685</pub-id>
<pub-id pub-id-type="pmid">24106704</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>EJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Stem cell engineering: limitation, alternatives, and insight</article-title>
<source/>Ann N Y Acad Sci
          <year>2011</year>
<volume>1229</volume>
<fpage>89</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="doi">10.1111/j.1749-6632.2011.06093.x</pub-id>
<pub-id pub-id-type="pmid">21793843</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Garcia</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ning</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Defining stem and progenitor cells within adipose tissue</article-title>
<source/>Stem Cells Dev
          <year>2008</year>
<volume>17</volume>
<fpage>1053</fpage>
<lpage>1063</lpage>
<pub-id pub-id-type="doi">10.1089/scd.2008.0117</pub-id>
<pub-id pub-id-type="pmid">18597617</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Matsubara</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Masuda</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characterization of adipose tissue-derived cells isolated with the Celution system</article-title>
<source/>Cytotherapy
          <year>2008</year>
<volume>10</volume>
<fpage>417</fpage>
<lpage>426</lpage>
<pub-id pub-id-type="doi">10.1080/14653240801982979</pub-id>
<pub-id pub-id-type="pmid">18574774</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lindroos</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Suuronen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Miettinen</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>The potential of adipose stem cells in regenerative medicine</article-title>
<source/>Stem Cell Rev
          <year>2011</year>
<volume>7</volume>
<fpage>269</fpage>
<lpage>291</lpage>
<pub-id pub-id-type="doi">10.1007/s12015-010-9193-7</pub-id>
<pub-id pub-id-type="pmid">20853072</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maumus</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Peyrafitte</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>D’Angelo</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Native human adipose stromal cells: localization, morphology and phenotype</article-title>
<source/>Int J Obes
          <year>2011</year>
<volume>35</volume>
<fpage>1141</fpage>
<lpage>1153</lpage>
<pub-id pub-id-type="doi">10.1038/ijo.2010.269</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mitchell</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>McIntosh</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Zvonic</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers</article-title>
<source/>Stem Cells
          <year>2006</year>
<volume>24</volume>
<fpage>376</fpage>
<lpage>385</lpage>
<pub-id pub-id-type="doi">10.1634/stemcells.2005-0234</pub-id>
<pub-id pub-id-type="pmid">16322640</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mizuno</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Adipose-derived stem cells for tissue repair and regeneration: ten years of research and a literature review</article-title>
<source/>J Nippon Med Sch
          <year>2009</year>
<volume>76</volume>
<fpage>56</fpage>
<lpage>66</lpage>
<pub-id pub-id-type="doi">10.1272/jnms.76.56</pub-id>
<pub-id pub-id-type="pmid">19443990</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mizuno</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tobita</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Uysal</surname>
<given-names>AC</given-names>
</name>
</person-group>
<article-title>Concise review: adipose-derived stem cells as a novel tool for future regenerative medicine</article-title>
<source/>Stem Cells
          <year>2012</year>
<volume>30</volume>
<fpage>804</fpage>
<lpage>810</lpage>
<pub-id pub-id-type="doi">10.1002/stem.1076</pub-id>
<pub-id pub-id-type="pmid">22415904</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagaya</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mizuno-Kamiya</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Takayama</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mechanisms of the immunosuppressive effects of mouse adipose tissue-derived mesenchymal stromal cells on mouse alloreactively stimulated spleen cells</article-title>
<source/>Exp Ther Med
          <year>2014</year>
<volume>7</volume>
<fpage>17</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="pmid">24348757</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakagami</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Morishita</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Maeda</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy</article-title>
<source/>J Atheroscler Thromb
          <year>2006</year>
<volume>13</volume>
<fpage>77</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.5551/jat.13.77</pub-id>
<pub-id pub-id-type="pmid">16733294</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neri</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bourin</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Peyrafitte</surname>
<given-names>JA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human Adipose Stromal Cells (ASC) for the Regeneration of Injured Cartilage Display Genetic Stability after in vitro culture expansion</article-title>
<source/>PLoS One
          <year>2013</year>
<volume>8</volume>
<fpage>e77895</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0077895</pub-id>
<pub-id pub-id-type="pmid">24205017</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olkowska-Truchanowicz</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Isolation and characterization of adipose tissue-derived stem cells</article-title>
<source/>Postepy Biol Komorki
          <year>2008</year>
<volume>35</volume>
<fpage>517</fpage>
<lpage>526</lpage>
</element-citation>
</ref>
<ref id="CR63">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orbay</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tobita</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mizuno</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Mesenchymal stem cells isolated from adipose and other tissues: basic biological properties and clinical applications</article-title>
<source/>Stem Cells Int
          <year>2012</year>
<volume>2012</volume>
<fpage>461718</fpage>
<pub-id pub-id-type="doi">10.1155/2012/461718</pub-id>
<pub-id pub-id-type="pmid">22666271</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patel</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Sherman</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Munoz</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Immunological properties of mesenchymal stem cells and clinical implications</article-title>
<source/>Arch Immunol Ther Exp
          <year>2008</year>
<volume>56</volume>
<fpage>1</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1007/s00005-008-0001-x</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peinado</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Pardo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>de la Rosa</surname>
<given-names>O</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Proteomic characterization of adipose tissue constituents, a necessary step for understanding adipose tissue complexity</article-title>
<source/>Proteomics
          <year>2012</year>
<volume>12</volume>
<fpage>607</fpage>
<lpage>620</lpage>
<pub-id pub-id-type="doi">10.1002/pmic.201100355</pub-id>
<pub-id pub-id-type="pmid">22246603</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pittenger</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Mackay</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Beck</surname>
<given-names>SC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Multilineage potential of adult human mesenchymal stem cells</article-title>
<source/>Science
          <year>1999</year>
<volume>284</volume>
<fpage>143</fpage>
<lpage>147</lpage>
<pub-id pub-id-type="doi">10.1126/science.284.5411.143</pub-id>
<pub-id pub-id-type="pmid">10102814</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prantl</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Muehlberg</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Navone</surname>
<given-names>NM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Adipose tissue-derived stem cells promote prostate tumor growth</article-title>
<source/>Prostate
          <year>2010</year>
<volume>70</volume>
<fpage>1709</fpage>
<lpage>1715</lpage>
<pub-id pub-id-type="doi">10.1002/pros.21206</pub-id>
<pub-id pub-id-type="pmid">20564322</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rada</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Reis</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gomez</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Novel method for the isolation of adipose stem cells (ASCs)</article-title>
<source/>J Tissue Eng Regen Med
          <year>2009</year>
<volume>3</volume>
<fpage>158</fpage>
<lpage>159</lpage>
<pub-id pub-id-type="doi">10.1002/term.141</pub-id>
<pub-id pub-id-type="pmid">19111010</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rangappa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>EH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes</article-title>
<source/>Ann Thorac Surg
          <year>2003</year>
<volume>75</volume>
<fpage>775</fpage>
<lpage>779</lpage>
<pub-id pub-id-type="doi">10.1016/S0003-4975(02)04568-X</pub-id>
<pub-id pub-id-type="pmid">12645692</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodbell</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis</article-title>
<source/>J Biol Chem
          <year>1964</year>
<volume>239</volume>
<fpage>375</fpage>
<lpage>380</lpage>
<pub-id pub-id-type="pmid">14169133</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodeheffer</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Birsoy</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Identification of white adipocyte progenitor cells in vivo</article-title>
<source/>Cell
          <year>2008</year>
<volume>135</volume>
<fpage>240</fpage>
<lpage>249</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2008.09.036</pub-id>
<pub-id pub-id-type="pmid">18835024</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rose</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro</article-title>
<source/>Stem Cells
          <year>2008</year>
<volume>26</volume>
<fpage>2884</fpage>
<lpage>2892</lpage>
<pub-id pub-id-type="doi">10.1634/stemcells.2008-0329</pub-id>
<pub-id pub-id-type="pmid">18687994</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rubio</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Garcia-Castro</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>MC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Spontaneous human adult stem cell transformation</article-title>
<source/>Cancer Res
          <year>2005</year>
<volume>65</volume>
<fpage>3035</fpage>
<lpage>3039</lpage>
<pub-id pub-id-type="pmid">15833829</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sachs</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Francis</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Defining essential stem cell characteristics in adipose-derived stromal cells extracted from distinct anatomical sites</article-title>
<source/>Cell Tissue Res
          <year>2012</year>
<volume>349</volume>
<fpage>505</fpage>
<lpage>515</lpage>
<pub-id pub-id-type="doi">10.1007/s00441-012-1423-7</pub-id>
<pub-id pub-id-type="pmid">22628159</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sadat</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gehmert</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>YH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF</article-title>
<source/>Biochem Biophys Res Commun
          <year>2007</year>
<volume>363</volume>
<fpage>674</fpage>
<lpage>679</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2007.09.058</pub-id>
<pub-id pub-id-type="pmid">17904522</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salgado</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Reis</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Sousa</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine</article-title>
<source/>Curr Stem Cell Res Ther
          <year>2010</year>
<volume>5</volume>
<fpage>103</fpage>
<lpage>110</lpage>
<pub-id pub-id-type="doi">10.2174/157488810791268564</pub-id>
<pub-id pub-id-type="pmid">19941460</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sensebe</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tarte</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Galipeau</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Limited acquisition of chromosomal aberrations in human adult mesenchymal stromal cells</article-title>
<source/>Cell Stem Cell
          <year>2012</year>
<volume>10</volume>
<fpage>9</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2011.12.005</pub-id>
<pub-id pub-id-type="pmid">22226349</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seo</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Miura</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gronthos</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Investigation of multipotent postnatal stem cells from human periodontal ligament</article-title>
<source/>Lancet
          <year>2004</year>
<volume>364</volume>
<fpage>149</fpage>
<lpage>155</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(04)16627-0</pub-id>
<pub-id pub-id-type="pmid">15246727</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seo</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Suh</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Bae</surname>
<given-names>YC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo</article-title>
<source/>Biochem Biophys Res Commun
          <year>2005</year>
<volume>328</volume>
<fpage>258</fpage>
<lpage>264</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2004.12.158</pub-id>
<pub-id pub-id-type="pmid">15670778</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skowrońska</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Fichna</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fichna</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>The role of adipose tissue in the endocrine system</article-title>
<source/>Endokr Otyłosc Zab Przem Mat
          <year>2005</year>
<volume>1</volume>
<fpage>21</fpage>
<lpage>29</lpage>
</element-citation>
</ref>
<ref id="CR81">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sood</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jayaraman</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sethi</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Liposuction: anaesthesia challenges</article-title>
<source/>Indian J Anaesth
          <year>2011</year>
<volume>55</volume>
<fpage>220</fpage>
<lpage>227</lpage>
<pub-id pub-id-type="doi">10.4103/0019-5049.82652</pub-id>
<pub-id pub-id-type="pmid">21808392</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sterodimas</surname>
<given-names>A</given-names>
</name>
<name>
<surname>de Faria</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nicaretta</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Tissue engineering with adipose-derived stem cells (ADSCs): current and future applications</article-title>
<source/>J Plast Reconstr Aesthet Surg
          <year>2010</year>
<volume>63</volume>
<fpage>1886</fpage>
<lpage>1892</lpage>
<pub-id pub-id-type="doi">10.1016/j.bjps.2009.10.028</pub-id>
<pub-id pub-id-type="pmid">19969517</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Timper</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Seboek</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Eberhardt</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells</article-title>
<source/>Biochem Biophys Res Commun
          <year>2006</year>
<volume>341</volume>
<fpage>1135</fpage>
<lpage>1140</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2006.01.072</pub-id>
<pub-id pub-id-type="pmid">16460677</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<mixed-citation publication-type="other">Tissue Genesis Incorporated (2009) Tissue Genesis Cell Isolation System. <ext-link ext-link-type="uri" xlink:href="http://www.tissuegenesis.com/adipose-derived-stem-cells.html">http://www.tissuegenesis.com/adipose-derived-stem-cells.html</ext-link>. Accessed 10 Feb 2009</mixed-citation>
</ref>
<ref id="CR85">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsuji</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Rubin</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Marra</surname>
<given-names>KG</given-names>
</name>
</person-group>
<article-title>Adipose-derived stem cells: implications in tissue regeneration</article-title>
<source/>World J Stem Cells
          <year>2014</year>
<volume>6</volume>
<fpage>312</fpage>
<lpage>321</lpage>
<pub-id pub-id-type="doi">10.4252/wjsc.v6.i3.312</pub-id>
<pub-id pub-id-type="pmid">25126381</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Utsunomiya</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Shimada</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Imura</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human adipose-derived stem cells: potential clinical applications in surgery</article-title>
<source/>Surg Today
          <year>2011</year>
<volume>41</volume>
<fpage>18</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="doi">10.1007/s00595-010-4415-9</pub-id>
<pub-id pub-id-type="pmid">21191687</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uzbas</surname>
<given-names>E</given-names>
</name>
<name>
<surname>May</surname>
<given-names>ID</given-names>
</name>
<name>
<surname>Parisi</surname>
<given-names>AM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular physiognomies and applications of adipose-derived stem cells</article-title>
<source/>Stem Cell Rev Rep
          <year>2015</year>
<volume>2</volume>
<fpage>298</fpage>
<lpage>308</lpage>
<pub-id pub-id-type="doi">10.1007/s12015-014-9578-0</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varma</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Breuls</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Schouten</surname>
<given-names>TE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Phenotypical and functional characterization of freshly isolated adipose tissue-derived stem cells</article-title>
<source/>Stem Cells Dev
          <year>2007</year>
<volume>16</volume>
<fpage>91</fpage>
<lpage>104</lpage>
<pub-id pub-id-type="doi">10.1089/scd.2006.0026</pub-id>
<pub-id pub-id-type="pmid">17348807</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vivek</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Amiti</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shivshankar</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Electrolyte and haemogram changes post large volume liposuction comparing two different tumescent solutions</article-title>
<source/>Indian J Plast Surg
          <year>2014</year>
<volume>47</volume>
<fpage>386</fpage>
<lpage>393</lpage>
<pub-id pub-id-type="pmid">25593425</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamamoto</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Gotoh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hattori</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy: report of two initial cases</article-title>
<source/>Int J Urol
          <year>2010</year>
<volume>17</volume>
<fpage>75</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="doi">10.1111/j.1442-2042.2009.02429.x</pub-id>
<pub-id pub-id-type="pmid">20002225</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yañez</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lamana</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>García-Castro</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease</article-title>
<source/>Stem Cells
          <year>2006</year>
<volume>24</volume>
<fpage>2582</fpage>
<lpage>2591</lpage>
<pub-id pub-id-type="doi">10.1634/stemcells.2006-0228</pub-id>
<pub-id pub-id-type="pmid">16873762</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yarak</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Okamoto</surname>
<given-names>OK</given-names>
</name>
</person-group>
<article-title>Human adipose-derived stem cells: current challenges and clinical perspectives</article-title>
<source/>An Bras Dermatol
          <year>2010</year>
<volume>85</volume>
<fpage>647</fpage>
<lpage>656</lpage>
<pub-id pub-id-type="doi">10.1590/S0365-05962010000500008</pub-id>
<pub-id pub-id-type="pmid">21152789</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshimura</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Shigeura</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates</article-title>
<source/>J Cell Physiol
          <year>2006</year>
<volume>208</volume>
<fpage>64</fpage>
<lpage>76</lpage>
<pub-id pub-id-type="doi">10.1002/jcp.20636</pub-id>
<pub-id pub-id-type="pmid">16557516</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshimura</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Aoi</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells</article-title>
<source/>Aesthetic Plast Surg
          <year>2008</year>
<volume>32</volume>
<fpage>48</fpage>
<lpage>55</lpage>
<pub-id pub-id-type="doi">10.1007/s00266-007-9019-4</pub-id>
<pub-id pub-id-type="pmid">17763894</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zack-Williams</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>PE</given-names>
</name>
<name>
<surname>Kalaskar</surname>
<given-names>DM</given-names>
</name>
</person-group>
<article-title>Current progress in use of adipose derived stem cells in peripheral nerve regeneration</article-title>
<source/>World J Stem Cells
          <year>2015</year>
<volume>7</volume>
<fpage>51</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="doi">10.4252/wjsc.v7.i1.51</pub-id>
<pub-id pub-id-type="pmid">25621105</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zannettino</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Paton</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Arthur</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo</article-title>
<source/>J Cell Physiol
          <year>2008</year>
<volume>214</volume>
<fpage>413</fpage>
<lpage>421</lpage>
<pub-id pub-id-type="doi">10.1002/jcp.21210</pub-id>
<pub-id pub-id-type="pmid">17654479</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeve</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Graff</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Fighting fat with fat: the expanding field of adipose stem cells</article-title>
<source/>Cell Stem Cell
          <year>2009</year>
<volume>5</volume>
<fpage>472</fpage>
<lpage>481</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2009.10.014</pub-id>
<pub-id pub-id-type="pmid">19896439</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zimmerlin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Donnenberg</surname>
<given-names>VS</given-names>
</name>
<name>
<surname>Pfeifer</surname>
<given-names>ME</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Stromal vascular progenitors in adult human adipose tissue</article-title>
<source/>Cytometry A
          <year>2010</year>
<volume>77</volume>
<fpage>22</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="pmid">19852056</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zimmerlin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Donnenberg</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Rubin</surname>
<given-names>JP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Regenerative therapy and cancer: in vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates</article-title>
<source/>Tissue Eng Part A
          <year>2011</year>
<volume>17</volume>
<fpage>93</fpage>
<lpage>106</lpage>
<pub-id pub-id-type="doi">10.1089/ten.tea.2010.0248</pub-id>
<pub-id pub-id-type="pmid">20673000</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zuk</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Adipose-derived stem cells in tissue regeneration: a review</article-title>
<source/>ISRN Stem Cells
          <year>2013</year>
<volume>2013</volume>
<fpage>713959</fpage>
<pub-id pub-id-type="doi">10.1155/2013/713959</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zuk</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mizuno</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Multilineage cells from human adipose tissue: implications for cell-based therapies</article-title>
<source/>Tissue Eng
          <year>2001</year>
<volume>7</volume>
<fpage>211</fpage>
<lpage>228</lpage>
<pub-id pub-id-type="doi">10.1089/107632701300062859</pub-id>
<pub-id pub-id-type="pmid">11304456</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>